Recall Z-2580-2024

Ortho-Clinical Diagnostics, Inc. · initiated July 3, 2024

Class II Open, Classified

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

VITROS Immunodiagnostic VITROS Folate Reagent Pack 1/2

Codes / lots: Model No 1513266; UDI/GTIN# 110758750009237; Lots within expiry: 3380, 3390, 3400, 3410, 3422, 3430, 3440, 3450, 3461, 3471, 3480.

Reason for recall

It was confirmed that fibrinogen in patient plasma samples precipitates out of solution upon the addition of folate stabilizer reagent as part of the pre-treatment process causing the increase in "TM5-4MB" condition codes which lead to a delay of results.

FDA-determined cause: Software Design Change

Action taken

On July 15, 2024, IMPORTANT PRODUCT CORRECTION NOTIFICATION letters were sent to customers. REQUIRED ACTION 1. Send the enclosed Customer Letter and Confirmation of Receipt form to all customers who were shipped VITROS Immunodiagnostic Products Folate Reagent Pack 1/2 from your facility within the past 12 months. 2. Complete the enclosed Confirmation of Receipt form no later than July 23, 2024. If you have further questions, please contact the Global Services Organization at 1-800-421-3311.

Details

Recall number
Z-2580-2024
Initiated
July 3, 2024
Posted by FDA
August 12, 2024
Product code
CGN – Acid, Folic, Radioimmunoassay
Quantity
18,467 units
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Columbia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapore, Sweden, United Kingdom.
Recalling firm
Ortho-Clinical Diagnostics, Inc., Rochester, NY

Official FDA recall record